These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 20407768)
21. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification. Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473 [TBL] [Abstract][Full Text] [Related]
22. Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma. Xiang X; Zhong JH; Wang YY; You XM; Ma L; Xiang BD; Li LQ Clin Transl Oncol; 2017 Jul; 19(7):891-897. PubMed ID: 28160206 [TBL] [Abstract][Full Text] [Related]
23. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas. Ni JY; Kong J; Sun HL; Chen YT; Luo JH; Wang WD; Chen D; Jiang XY; Xu LF Acad Radiol; 2018 Apr; 25(4):423-429. PubMed ID: 29198946 [TBL] [Abstract][Full Text] [Related]
24. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study. Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620 [TBL] [Abstract][Full Text] [Related]
25. Combined hepatectomy and radiofrequency ablation versus TACE in improving survival of patients with unresectable BCLC stage B HCC. Hou YF; Wei YG; Yang JY; Wen TF; Xu MQ; Yan LN; Li B Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):378-85. PubMed ID: 27498577 [TBL] [Abstract][Full Text] [Related]
26. Cancer of the Liver Italian Program score helps identify potential candidates for transarterial chemoembolization in patients with Barcelona Clinic Liver Cancer stage C. Li L; Gou CY; Li JY; Achakzai R; Li XH Hepatobiliary Pancreat Dis Int; 2016 Apr; 15(2):152-7. PubMed ID: 27020631 [TBL] [Abstract][Full Text] [Related]
27. [Comparison liver resection with transarterial chemoembolization for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma patients on long-term survival after SPSS propensity score matching]. Ke Y; Zhong J; Guo Z; Liang Y; Li L; Xiang B Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):747-50. PubMed ID: 24844957 [TBL] [Abstract][Full Text] [Related]
29. Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score. Op den Winkel M; Nagel D; Op den Winkel P; Trojan J; Paprottka PM; Steib CJ; Schmidt L; Göller M; Stieber P; Göhring P; Herbst A; Rentsch M; De Toni EN; Göke B; Gerbes AL; Kolligs FT Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):44-53. PubMed ID: 29076939 [TBL] [Abstract][Full Text] [Related]
30. Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma. Wang X; Wang Z; Wu L BMC Surg; 2016 Apr; 16():22. PubMed ID: 27094483 [TBL] [Abstract][Full Text] [Related]
31. Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases. Di Sandro S; Centonze L; Pinotti E; Lauterio A; De Carlis R; Romano F; Gianotti L; De Carlis L; Updates Surg; 2019 Jun; 71(2):285-293. PubMed ID: 30941704 [TBL] [Abstract][Full Text] [Related]
32. Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis. Zhu SL; Ke Y; Peng YC; Ma L; Li H; Li LQ; Zhong JH PLoS One; 2014; 9(12):e115834. PubMed ID: 25541684 [TBL] [Abstract][Full Text] [Related]
33. Liver resection improves the survival of patients with multiple hepatocellular carcinomas. Ho MC; Huang GT; Tsang YM; Lee PH; Chen DS; Sheu JC; Chen CH Ann Surg Oncol; 2009 Apr; 16(4):848-55. PubMed ID: 19159983 [TBL] [Abstract][Full Text] [Related]
34. Surgical resection versus transarterial chemoembolization for BCLC intermediate stage hepatocellular carcinoma: a systematic review and meta-analysis. Liang L; Xing H; Zhang H; Zhong J; Li C; Lau WY; Wu M; Shen F; Yang T HPB (Oxford); 2018 Feb; 20(2):110-119. PubMed ID: 29174493 [TBL] [Abstract][Full Text] [Related]
35. Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: A meta-analysis of high-quality studies. Hyun MH; Lee YS; Kim JH; Lee CU; Jung YK; Seo YS; Yim HJ; Yeon JE; Byun KS Hepatology; 2018 Sep; 68(3):977-993. PubMed ID: 29543988 [TBL] [Abstract][Full Text] [Related]
36. Transarterial chemoembolization in Barcelona Clinic Liver Cancer Stage 0/A hepatocellular carcinoma. Kim HC; Suk KT; Kim DJ; Yoon JH; Kim YS; Baik GH; Kim JB; Kim CH; Sung H; Choi JY; Han KH; Park SH World J Gastroenterol; 2014 Jan; 20(3):745-54. PubMed ID: 24574748 [TBL] [Abstract][Full Text] [Related]
37. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma. Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016 [TBL] [Abstract][Full Text] [Related]
38. NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization. Adhoute X; Pénaranda G; Raoul JL; Bollon E; Pol B; Letreut YP; Perrier H; Bayle O; Monnet O; Beaurain P; Muller C; Hardwigsen J; Lefolgoc G; Castellani P; Bronowicki JP; Bourlière M Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):706-715. PubMed ID: 28195873 [TBL] [Abstract][Full Text] [Related]
39. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma. Hirooka M; Hiraoka A; Ochi H; Kisaka Y; Joko K; Michitaka K; Hiasa Y AJR Am J Roentgenol; 2018 Apr; 210(4):891-898. PubMed ID: 29412017 [TBL] [Abstract][Full Text] [Related]
40. Preoperative adjuvant transarterial chemoembolization cannot improve the long term outcome of radical therapies for hepatocellular carcinoma. Jianyong L; Jinjing Z; Lunan Y; Jingqiang Z; Wentao W; Yong Z; Bo L; Tianfu W; Jiaying Y Sci Rep; 2017 Feb; 7():41624. PubMed ID: 28155861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]